Jiyuan Medical has completed the second phase of Series A financing, focusing on building a leading global market position

Recently, Jiangsu Jiyuan Medical Technology Co., Ltd. (hereinafter referred to as "Jiyuan Medical") announced the completion of the second phase of Series A financing of tens of millions of yuan, following the first phase of Series A financing in 2023. The funds raised in this round of financing will mainly be used for the research and development, global registration and certification, production, and market promotion of disposable electronic hysteroscopes and supporting disposable surgical instruments, further expanding competitive advantages and laying the foundation for ARMI ® The market position of the brand as "China's number one and global leader".

Jiangsu Jiyuan Medical Technology Co., Ltd

Jiyuan Medical was established in 2017, focusing on the research and development, production, and sales of disposable gynecological endoscopes, committed to creating a "comprehensive solution for disposable gynecological endoscopes". Led by disposable electronic hysteroscopes, we provide a series of disposable electronic hysteroscopes and matching disposable surgical instruments that meet the diagnosis and treatment needs of all surgical scenarios for uterine diseases. Through independent innovation and optimization integration, establish a multi product technology platform for disposable endoscopes, and create a comprehensive solution for disposable gynecological endoscopes that conforms to the 3A+gynecological endoscope technology concept and the "five in one" approach. Global synchronous registration and certification, promoting the diagnosis and treatment concept of Natural Orifice Transluminal Endoscopic Surgery (NOTEs), gradually leading the new era of disposable gynecological endoscopes 3A+.

Jiangsu Jiyuan Medical Technology Co., Ltd

3A+is the first endoscopic diagnosis and treatment technology concept proposed by Jiyuan Medical in the world. Jiyuan Medical has always focused on the 3A+concept in research and development, manufacturing, marketing, and medical services. 3A+specifically refers to 'No Cross Infection Risk' at any time, anywhere, anyone.

Jiyuan Medical First Generation Equipment

As of 2023, Jiyuan Medical has launched 72 specifications and models of disposable electronic hysteroscopes and over 200 specifications and models of disposable surgical instruments, and has initially established a comprehensive solution for disposable electronic hysteroscopes.

The ARMI disposable electronic hysteroscope series has passed registration and certification in more than 10 countries and regions, including China NMPA, the US FDA, and the EU CE-MDR. Its sales network covers more than 30 countries and regions including China, Southeast Asia, the Middle East, the United States, and Europe. Jiyuan Medical passed the ISO13485 quality system certification in November 2021. The ARMI ® series uses medical grade chips, modularization, and semi-automatic batch production. After a multi center clinical control study, and the use of nearly 10000 patients in more than 800 hospitals around the world, its product quality, functional performance, quality consistency, and technological progressiveness have reached the international leading level, so it has won the unanimous praise of thousands of doctors around the world.

Jiyuan Medical's first generation disposable electronic hysteroscope

In July 2022, Professor Cao Zeyi (former Deputy Minister of Health and renowned gynecological expert), the medical consultant of Jiyuan Medical, personally visited Jiyuan Medical and evaluated the ARMI during the on-site inspection ® The disposable electronic hysteroscope series will trigger significant changes in the medical field. In September 2023, Dr. ARMI series global medical consultant Resad Paya Pasic (former President of the International Society of Gynecological Endoscopy), Dr. Adel Shervin (former Executive Director of the International Society of Gynecological Endoscopy), and Dr Eddy Hartono (current president of the International Society of Gynecological Endoscopy) and his delegation visited Jiyuan Medical and unanimously declared, "An important medical revolution is unfolding globally by Jiyuan Medical. Dr. Resad Paya Pasic also conducted on-site discussions on ARMI ® The brand has highly interpreted "Advanced Medical Research Institute".

After 6 years of intensive cultivation, ARMI ® has achieved a leading position in many aspects such as registration access, product quality, and market coverage in the industry, and is steadily moving towards the market goal of "China's first and world leading" with its head held high!

Jiyuan Medical's first generation disposable electronic uterine cavity+disposable endoscopic scissors

Hysteroscopy is the "gold standard" for diagnosing uterine lesions! According to statistics, the annual number of cases diagnosed and treated with hysteroscopy worldwide has reached 40 million, with China alone accounting for 12 million cases and an annual growth rate of over 10%. Professor Feng Limin, a renowned expert in hysteroscopy in China, said, "In order to meet the increasing demand for diagnosis and treatment of uterine diseases and diversified needs (more efficient, minimally invasive, convenient, painless, and safe), it is necessary to vigorously promote the concept of comprehensive management of hysteroscopy." Hysteroscopy diagnosis and treatment are widely carried out in outpatient clinics, day surgeries, and central operating rooms, especially in outpatient hysteroscopy that conforms to the principle of "appointment and treatment".

Disposable electronic hysteroscopes have the characteristics of high electronic degree, thin body (≤ 5.0mm), 5Fr-6Fr instrument channel, and circulating perfusion, which meet the technical requirements for hysteroscopic vaginal endoscopy and the outpatient hysteroscopy diagnosis and treatment concept of "appointment and treatment". The use of disposable electronic hysteroscopes with "clamp" technology in conjunction with disposable endoscopic surgical instruments, and the implementation of "five exemptions" (no speculum, no hysteroscopy, no dilation, no clamping, and no anesthesia) hysteroscopy diagnosis and treatment, will maximize the efficiency of diagnosis and treatment, reduce cervical damage and protect fertility, and truly avoid the risk of cross infection; Especially suitable for patients with uterine abnormalities, failure of traditional hysteroscopy, special diseases, and no sexual history. Therefore, disposable electronic hysteroscopes will become the cornerstone of gynecological clinics and day surgeries worldwide.

Jiyuan Medical's second-generation disposable electronic hysteroscope

Against the backdrop of increasingly fierce competition in the global medical equipment market, sustained technological innovation and market sensitivity are key to the survival and development of enterprises. In January 2024, the second generation of ARMI ® disposable electronic hysteroscope series, consisting of 60 specifications, passed NMPA registration certification.

The second generation of ARMI not only inherits the functional and performance advantages of the first generation, but also has lower costs; It can quickly enter the high-end markets of developed countries such as Europe and America, and also adapt to the mid to low end markets of Southeast Asia, Africa, and other countries; While reducing the cost of medical treatment for patients, it also further enhances the allocation of primary healthcare resources and service capabilities. The second generation of ARMI adopts high-definition resolution chip modules and is equipped with high-performance image processors, greatly improving the data processing ability and signal processing level in complex uterine cavity environments. It can effectively identify and diagnose hidden lesions, reduce missed diagnosis or accidents.

Jiyuan Medical Second Generation Equipment

By 2024, the ARMI ® disposable electronic hysteroscope series will have completed registration and certification in over 130 countries and regions, with sales networks covering more than 90 countries, establishing its market position as "China's first and world leading", leading the global era of 3A+hysteroscopy diagnosis and treatment, and benefiting millions of patients with uterine diseases worldwide.

Regarding this financing, Zhang Yunfei, Chairman of Jiyuan Medical, stated that the disposable endoscope industry has a huge market space globally, and Chinese and foreign companies are on the same starting line. In the field of gynecology, Jiyuan Medical is even at the forefront of the world, competing with leading global enterprises on the same stage. Thank you very much to all investors for their recognition of the company, which has injected strong strategic momentum into the cause of human health. With the strong support of new and old shareholders, we will fully utilize our product technology research and development advantages, continuously deepen our capture and understanding of clinical needs, and comprehensively enhance our ability to translate needs into products and solutions in the design and production processes. On the market side, the company will strive to accelerate global commercialization promotion, especially in high-end markets such as Greater China and Europe and America, to provide valuable products and services to more doctors and patients, and deliver satisfactory results to shareholders within three years.